Medical Research News
-
Updated 18 minutes ago
Confidence in the market for Impressionist and modern art was boosted last night in London as a $165 million auction beat its high estimate, helped by Claude Monet’s painting of a Venetian palazzo.
-
The Iranian rial, whose plunge triggered an inflation crisis, is gaining in the unregulated market after President-elect Hassan Rohani said he would seek to ease international sanctions crippling the economy.
-
Iranian President-elect Hassan Rohani said he will make the country’s nuclear program more transparent as he seeks to ease tension with the U.S. and reduce “brutal” sanctions that have crippled the economy.
-
U.S. President Barack Obama and Russian President Vladimir Putin expressed optimism that the election in Iran may open a new avenue for ending the standoff over the Islamic republic’s nuclear program.
-
Iranian President-Elect Hassan Rohani’s vow to improve ties with the world carried him to a surprise first-round win. It also may have rewound the clock on a potential military strike against his country over its nuclear program.
-
West Texas Intermediate crude rose to a four-month high after President Barack Obama was said to authorize arming Syrian rebels groups, ratcheting up tensions in a region home to about a third of the world’s oil supply.
-
Index Ventures, an early investor in photo-sharing service Dropbox Inc., spent $11 million creating a company to develop an antibody-based clot-busting drug intended to treat heart attacks or strokes while limiting bleeding.
-
Hassan Rohani, who criticized government intervention in Iranian lives and pledged dialogue with the world, won the nation’s presidency with enough backing to avoid a second-round vote.
-
West Texas Intermediate climbed to its highest intraday level in 10 weeks on signs of economic recovery in the U.S., the world’s largest consumer of crude, and concern that Middle East exports may be disrupted.
-
The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page